-Search query
-Search result
Showing 1 - 50 of 507 items for (author: burton & dr)
EMDB-40981:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40982:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8t2e:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8t2f:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40812:
Structure of SARS-CoV-2 (HP-GSAS-Mut7) spike in complex with TXG-0078 Fab -Conformation 1
Method: single particle / : Bangaru S, Ward AB
EMDB-40813:
Structure of SARS-CoV-2 (HP-GSAS-Mut7) spike in complex with TXG-0078 Fab -Conformation 2
Method: single particle / : Bangaru S, Ward AB
EMDB-40822:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40823:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40824:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
PDB-8swv:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8sww:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
PDB-8swx:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40814:
Local refinement of SARS-CoV-2 (HP-GSAS-Mut7) spike NTD in complex with TXG-0078 Fab
Method: single particle / : Bangaru B, Ward A
PDB-8swh:
Local refinement of SARS-CoV-2 (HP-GSAS-Mut7) spike NTD in complex with TXG-0078 Fab
Method: single particle / : Bangaru B, Ward A
EMDB-40825:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB
PDB-8sx3:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB
EMDB-41024:
MD65 N332-GT5 SOSIP in complex with RM_N332_03 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB
EMDB-41025:
MD65 N332-GT5 SOSIP in complex with RM_N332_36 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB
EMDB-41026:
MD65 N332-GT5 SOSIP in complex with RM_N332_32 Fab and RM20A3
Method: single particle / : Ozorowski G, Torres JL, Ward AB
EMDB-41027:
MD65 N332-GT5 SOSIP in complex with RM_N332_08 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB
EMDB-41034:
MD64 N332-GT5 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Ward AB
EMDB-41035:
MD65 N332-GT5 SOSIP in complex with RM_N332_07 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB
PDB-8t49:
MD65 N332-GT5 SOSIP in complex with RM_N332_03 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB
PDB-8t4a:
MD65 N332-GT5 SOSIP in complex with RM_N332_36 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB
PDB-8t4b:
MD65 N332-GT5 SOSIP in complex with RM_N332_32 Fab and RM20A3
Method: single particle / : Ozorowski G, Torres JL, Ward AB
PDB-8t4d:
MD65 N332-GT5 SOSIP in complex with RM_N332_08 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB
PDB-8t4k:
MD64 N332-GT5 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Ward AB
PDB-8t4l:
MD65 N332-GT5 SOSIP in complex with RM_N332_07 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB
EMDB-40242:
BG505 MD39 SOSIP in complex with Rh.NJ85 wk12 gp120GH, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40243:
BG505 MD39 SOSIP in complex with Rh.NJ86 wk12 V1V3, C3V5, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40244:
BG505 MD39 SOSIP in complex with Rh.NJ76 wk12 C3V5, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40252:
BG505 MD39 SOSIP in complex with Rh.NK04 wk12 gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40254:
BG505 MD39 SOSIP in complex with Rh.NJ75 wk12 gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40255:
BG505 MD39 SOSIP in complex with Rh.NJ87 wk12 C3V5 and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40256:
BG505 MD39 SOSIP in complex with Rh.NJ84 wk12 V1V3, gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40257:
BG505 MD39 SOSIP in complex with Rh.NJ77 wk12 V1V3, C3V5, N611/FP and base epitope polyclonal
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40803:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40804:
BG505 Boost2 SOSIP.664 in complex with NHP Polyclonal Antibody FP4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40805:
BG505 Boost 2 in complex with NHP antibody V1V2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40806:
BG505 Boost 2 in complex with NHP Polyclonal Antibody N625
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40807:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base1
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40808:
Boost 2 SOSIP.664 in complex with NHP polyclonal antibody Base2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40809:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40810:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8sw7:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-27692:
LM18/Nb136 bispecific tetra-nanobody immunoglobulin in complex with SARS-CoV-2-6P-Mut7 S protein (focused refinement)
Method: single particle / : Ozorowski G, Turner HL, Ward AB
EMDB-27693:
LM18/Nb136 bispecific tetra-nanobody immunoglobulin in complex with SARS-CoV-2-6P-Mut7 S protein (global refinement)
Method: single particle / : Ozorowski G, Turner HL, Ward AB
PDB-8dt8:
LM18/Nb136 bispecific tetra-nanobody immunoglobulin in complex with SARS-CoV-2-6P-Mut7 S protein (focused refinement)
Method: single particle / : Ozorowski G, Turner HL, Ward AB
EMDB-14784:
AMC009 SOSIPv5.2 + ACS110 Fab
Method: single particle / : van Schooten J, Ward A
EMDB-14785:
AMC009 SOSIPv.52 in complex with ACS114 Fab
Method: single particle / : van Schooten J, Ward A
Pages: